“I see a very innovation-friendly climate in Basel”
It all began with research resources that were a quarter of a century old. Simon Ittig and his colleagues at the Biozentrum of the University…
clement12.04.2017
BaseLaunch can take full advantage of the potential of Basel’s life sciences ecosystem
The new accelerator for healthcare ventures, BaseLaunch, wants to link the best start-ups to the Basel region – and in doing so, provide impulses for…
clement30.03.2017
Clozel’s Actelion R&D spinout gets a name
→ Jean-Paul Clozel has a name for his biotech spinout. Once J&J’s $30 billion deal to acquire Actelion goes through, the R&D side of the…
clement15.03.2017
Non-dilutive funding: Event gives an overview of funding sources
Innovation is the key to success for SMEs and start-ups. But they need money for this. One way to develop and maintain innovative business areas…
clement15.03.2017
BaseLaunch wants to bring the best healthcare start-ups to Basel
“If we invest billions in university research, then this remains an abortive effort if we do not make sure at the same time that these…
clement15.03.2017
Genentech to start new trial for Alzheimer’s drug
Genentech, an American subsidiary of the Basel-based pharmaceutical company Roche, will start a second Phase 3 clinical trial for its Alzheimer’s therapy crenezumab.
clement01.03.2017
BioMedPartners announces first closing of new fund
The Basel-based venture capital firm BioMedPartners has raised CHF 75 million in the first closing of their fund BioMedInvest III, a healthcare venture capital fund…
clement17.02.2017
